Rs 4.47 crore cash seized in Hyderabad ESI scam

Hyderabad(Hyd), September 1 : Telangana (TL)’s Anti-Corruption Bureau has captured INR 4.47 cr in unaccounted money from previous director of Insurance Medical Solutions (IMC) Devika Rani & her colleague Naga Lakshmi.

The amount has been captured from a real estate firm in Hyderabad(Hyd) throughout interrogations into the disproportionate assets complaint.

The anti-graft agency stated the amount has been invested to buy commercial & residential space in Cyberabad region here.

Devika Rani, who reportedly deceived the govt of INR nine cr using fraud medical invoices, had made payment INR 3.75 cr awhile Naga Lakshmi, a pharmacist, made payment INR 72 lakh to purchase the property.

“Both the charged officials had invested this unaccounted amount towards the buy of six residential flats & regarding 15,000 square ft of commercial space within the names of their own family (4) members,” the ACB stated.

Devika Rani had also invested INR 22 lakh in ‘benamis’. The detectives also detected the other INR 2.29 cr made payment using cheques & on-line transfers using different sources to buy the property. The same is now in the procedure of seizure, an officer said.

Both the charged officials have been already detained within the disproportionate assets complaint & they have been declared on bail by a court.

It has been in Sep previous year that the ACB had detained afterwards director Devika Rani & 6 remaining in a multi-crore scam in delivery of medicines to dispensaries & hospitals within the Employees State Insurance (ESI) scheme.

The director & different authorities reportedly caused losses to the govt exchequer by buying medicines using special medical drug dispensing units in place of ‘rate contract’ companies throughout 2017-18.

Devika Rani reportedly diverted multiple crores of rupees by buying drugs & surgical kits from unauthorised companies within the guise of urgency. The charged have been charged with creating false indents, falsifying reports & violating regulations in buying medicines.

The anti-graft agency had initiated an investigation into the scam following directions from that state govt.

The Vigilance & Enforcement Wing had previously held a probe into the allegations that Devika Rani didn’t follow the eligibility criteria in selection of companies for delivery of medicines. The probe identified that the medicines have been took in outrageous costs, in violation of the procurement methods & e-tender procedure.

In Oct, the state govt had discontinued Devika Rani & 6 different authorities in connection with the scam.